- Report
- October 2025
- 87 Pages
United States
From €4303EUR$4,850USD£3,725GBP
- Report
- October 2025
- 97 Pages
Asia Pacific
From €4303EUR$4,850USD£3,725GBP
From €4303EUR$4,850USD£3,725GBP
- Report
- October 2025
- 100 Pages
Middle East
From €4303EUR$4,850USD£3,725GBP
- Report
- September 2025
- 95 Pages
United States
From €4303EUR$4,850USD£3,725GBP
- Report
- June 2025
- 96 Pages
Asia Pacific
From €3505EUR$3,950USD£3,034GBP
- Report
- June 2025
- 98 Pages
Europe
From €3505EUR$3,950USD£3,034GBP
- Report
- June 2025
- 88 Pages
North America
From €3061EUR$3,450USD£2,650GBP
- Report
- February 2022
- 131 Pages
Global
From €4258EUR$4,799USD£3,686GBP
- Report
- April 2022
- 350 Pages
Global
From €4258EUR$4,799USD£3,686GBP
- Report
- January 2026
Global
From €300EUR$362USD£269GBP
- Report
- July 2022
- 263 Pages
Global
From €1800EUR$2,173USD£1,613GBP
- Report
- June 2023
- 389 Pages
Global
From €4723EUR$5,509USD£3,950GBP
- Report
- April 2022
- 131 Pages
Global
From €1153EUR$1,299USD£998GBP
- Report
- January 2026
Global
From €450EUR$543USD£403GBP
- Report
- November 2024
- 478 Pages
Global
From €4392EUR$4,950USD£3,802GBP
- Report
- January 2025
- 140 Pages
Global
From €1597EUR$1,800USD£1,383GBP
€2130EUR$2,400USD£1,844GBP
- Report
- January 2024
- 140 Pages
Global
From €2196EUR$2,475USD£1,901GBP
€2928EUR$3,300USD£2,535GBP
- Report
- January 2025
- 100 Pages
Global
From €1597EUR$1,800USD£1,383GBP
€2130EUR$2,400USD£1,844GBP
- Report
- August 2024
- 180 Pages
Global
From €1597EUR$1,800USD£1,383GBP
€2130EUR$2,400USD£1,844GBP

The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments.
The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more